alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 2,951–2,975 of 7,816 matching trials · page 119 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Delivery Format of Cognitive Behavioral Therapy Materials on Engagement and Outcomes: AI-Enabled App vs PDF Workbook
NCT06459128
Limbic Care; Digital Workbook
Runs in: United Kingdom · 1 site 		NA
other		 COMPLETED 540 Limbic Limited
INDUSTRY		 2024-12-06
Effects on Dementia Caregivers
NCT06473571
Intervention Protocol (The 3GT); Control Group
Runs in: United States · 1 site 		NA
other		 COMPLETED 50 University of Central Florida
OTHER		 2024-12-06
App-based Consent for Pediatric Clinical Research
NCT05880147
Consent App; Traditional paper-based consent
Runs in: Canada · 1 site 		NA
other		 COMPLETED 120 University of British Columbia
OTHER		 2024-12-05
Probiotics in Mild Alzheimer's Disease
NCT06181513
Probiotic Blend Capsule
Runs in: Cyprus · 1 site 		EARLY_PHASE1
other		 RECRUITING 40 University of Nicosia
OTHER		 2024-12-05
Cognitive Integrated Motor Training (CM) to Improve Gait and Balance and Reduce Falls in Older Adults With Mild Cognitive Impairment
NCT06719297
Personalized cognitive-sensorimotor VR/MR training; Standard of Care
Runs in: United States · 1 site 		NA
other		 NOT_YET_RECRUITING 40 Kessler Foundation
OTHER		 2024-12-05
Prevalence of Alzheimer's Disease Pathology in the Community
NCT06719453 		NA
other		 COMPLETED 9,663 Helse Stavanger HF
OTHER_GOV		 2024-12-05
Personalized Nutrition and eHealth: Lifestyle Intervention (LION) Study for Weight Loss Maintenance
NCT04023942
Weight maintenance intervention
Runs in: Germany · 1 site 		NA
other		 COMPLETED 272 Technical University of Munich
OTHER		 2024-12-04
Multidomain Interventions Via Face-to-face and Video Communication Platforms in Mild Cognitive Impairment
NCT05023057
Multidomain intervention
Runs in: South Korea · 17 sites 		NA
other		 COMPLETED 300 Inha University Hospital
OTHER		 2024-12-04
Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease
NCT05670912
Wei Li Bai capsules; Placebo Comparator of Wei Li Bai capsules
Runs in: China · 3 sites 		PHASE2
other		 TERMINATED 105 Capital Medical University
OTHER		 2024-12-04
Supplemental Hydrogen Plus PQQ for Mitochondrial Biomarkers and Brain Function in Elderly With Mild Cognitive Impairment
NCT05910047
Supplement; Placebo
Runs in: Serbia · 1 site 		NA
other		 COMPLETED 34 University of Novi Sad, Faculty of Sport and Physical Education
OTHER		 2024-12-04
Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults
NCT06715995
Gamma Wave Stimulation Table Lamp (Aleddra, Inc., USA)
Runs in: Taiwan · 1 site 		NA
other		 RECRUITING 52 Chang Gung Memorial Hospital
OTHER		 2024-12-04
Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia
NCT04769024
LUMEEN Virtual Reality sessions; Control/non-digital stimulation sessions
Runs in: France · 6 sites 		NA
other		 COMPLETED 56 Hospices Civils de Lyon
OTHER		 2024-12-03
Determination of Walking, Balance, Fall Risk and Kinesiophobia in Individulas with Alzheimer's Dementation
NCT05201768
balance tests,questionnaire
Runs in: Turkey (Türkiye) · 1 site 		NA
other		 COMPLETED 41 Kırıkkale University
OTHER		 2024-12-03
Role of Gait Analysis in Different Type of Dementia
NCT06713070 		NA
other		 NOT_YET_RECRUITING 102 Assiut University
OTHER		 2024-12-03
A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders
NCT04739423
clenbuterol (CST-103), nadolol (CST-107), matching placebo
Runs in: Australia; New Zealand; United Kingdom · 7 sites 		PHASE2
other		 COMPLETED 41 CuraSen Therapeutics, Inc.
INDUSTRY		 2024-12-02
LEAD IT! An App to Enable Persons With Early Stage Dementia to Lead Group Activities for Their Peers
NCT05516342
LEAD IT! Programming
Runs in: United States · 1 site 		NA
other		 COMPLETED 182 Hopeful Aging
INDUSTRY		 2024-12-02
Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment
NCT04078178
Niagen; Placebo Comparator
Runs in: United States · 1 site 		NA
other		 COMPLETED 61 Steven E Arnold, MD
OTHER		 2024-11-29
Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
NCT04735536
CT1812; Placebo
Runs in: Netherlands · 1 site 		PHASE2
other		 COMPLETED 16 Cognition Therapeutics
INDUSTRY		 2024-11-29
Enhancing Language Function in Primary Progressive Aphasia
NCT04920318
tDCS + language therapy; sham TDCS + language therapy
Runs in: United States · 1 site 		NA
other		 RECRUITING 20 University of Arizona
OTHER		 2024-11-29
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)
NCT05108922
Donanemab; Aducanumab
Runs in: United States · 31 sites 		PHASE3
anti-amyloid-antibody		 COMPLETED 148 Eli Lilly and Company
INDUSTRY		 2024-11-29
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease
NCT05147428
Educational Materials
Runs in: United States · 1 site 		NA
other		 COMPLETED 14,442 University of Massachusetts, Worcester
OTHER		 2024-11-27
Shared Decision Making About Medication Use for People With Multiple Health Problems
NCT05156073
Educational Materials
Runs in: United States · 1 site 		NA
other		 COMPLETED 22 Johns Hopkins University
OTHER		 2024-11-27
A One-year Trajectory of Depression Status Changes in Older Adults With MCI and SD: a Longitudinal Cohort Study
NCT06308627
Runs in: China · 1 site 		NA
other		 COMPLETED 466 Fujian Medical University
OTHER		 2024-11-27
Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease
NCT06706947
Lymphaticovenous Anastomosis
Runs in: China · 1 site 		NA
other		 NOT_YET_RECRUITING 20 Luo Xinxin
OTHER		 2024-11-27
Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid
NCT02719327
icosapent ethyl (IPE); gel cap placebo
Runs in: United States · 1 site 		PHASE2|PHASE3
other		 COMPLETED 131 VA Office of Research and Development
OTHER_GOV		 2024-11-26

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →